attack. Chest. 2003 Apr;123(4):1018-25. \[[PubMed: 12684289](https://pubmed.ncbi.nlm.nih.gov/12684289)\] 42. Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002742. \[[PMC free article: PMC7093892](/pmc/articles/PMC7093892/)\] \[[PubMed: 23235591](https://pubmed.ncbi.nlm.nih.gov/23235591)\] 43. Cremer NM, Baptist AP. Race and Asthma Outcomes in Older Adults: Results from the National Asthma Survey. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1294-1301.e7. \[[PubMed: 32035849](https://pubmed.ncbi.nlm.nih.gov/32035849)\] 44. Nardone A, Casey JA, Morello-Frosch R, Mujahid M, Balmes JR, Thakur N. Associations between historical residential redlining and current age-adjusted rates of emergency department visits due to asthma across eight cities in California: an ecological study. Lancet Planet Health. 2020 Jan;4(1):e24-e31. \[[PMC free article: PMC10018700](/pmc/articles/PMC10018700/)\] \[[PubMed: 31999951](https://pubmed.ncbi.nlm.nih.gov/31999951)\] 45. Song WJ, Lee JH, Kang Y, Joung WJ, Chung KF. Future Risks in Patients With Severe Asthma. Allergy Asthma Immunol Res. 2019 Nov;11(6):763-778. \[[PMC free article: PMC6761069](/pmc/articles/PMC6761069/)\] \[[PubMed: 31552713](https://pubmed.ncbi.nlm.nih.gov/31552713)\] **Disclosure:** Jennifer Goldin declares no relevant financial relationships with ineligible companies. **Disclosure:** Muhammad Hashmi declares no relevant financial relationships with ineligible companies. **Disclosure:** Mary Cataletto declares no relevant financial relationships with ineligible companies.